These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23079530)

  • 1. Novel progesterone receptor modulators: 4-aryl-phenylsulfonamides.
    McComas C; Cohen J; Huselton C; Marella M; Melenski E; Mugford C; Slayden O; Winneker R; Wrobel J; Yudt MR; Fensome A
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7119-22. PubMed ID: 23079530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget.
    Fensome A; Bender R; Chopra R; Cohen J; Collins MA; Hudak V; Malakian K; Lockhead S; Olland A; Svenson K; Terefenko EA; Unwalla RJ; Wilhelm JM; Wolfrom S; Zhu Y; Zhang Z; Zhang P; Winneker RC; Wrobel J
    J Med Chem; 2005 Aug; 48(16):5092-5. PubMed ID: 16078826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Aryl indanones and derivatives as non-steroidal progesterone receptor modulators.
    Kern JC; Terefenko E; Trybulski E; Berrodin TJ; Cohen J; Winneker RC; Yudt MR; Zhang Z; Zhu Y; Zhang P
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6666-9. PubMed ID: 19864132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist.
    Zhang P; Terefenko E; Kern J; Fensome A; Trybulski E; Unwalla R; Wrobel J; Lockhead S; Zhu Y; Cohen J; Lacava M; Winneker RC; Zhang Z
    Bioorg Med Chem; 2007 Oct; 15(20):6556-64. PubMed ID: 17681796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Methyl-1H-pyrrole-2-carbonitrile containing tetrahydronaphthalene derivatives as non-steroidal progesterone receptor antagonists.
    Kern JC; Terefenko E; Trybulski E; Berrodin TJ; Cohen J; Winneker RC; Yudt MR; Zhang Z; Zhu Y; Zhang P
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4816-8. PubMed ID: 20638844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7-aryl 1,5-dihydro-benzo[e][1,4]oxazepin-2-ones and analogs as non-steroidal progesterone receptor antagonists.
    Zhang P; Kern JC; Terefenko EA; Fensome A; Unwalla R; Zhang Z; Cohen J; Berrodin TJ; Yudt MR; Winneker RC; Wrobel J
    Bioorg Med Chem; 2008 Jul; 16(13):6589-600. PubMed ID: 18504132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,5-Dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5'-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulators.
    Kern JC; Terefenko EA; Fensome A; Unwalla R; Wrobel J; Cohen J; Zhu Y; Berrodin TJ; Yudt MR; Winneker RC; Zhang Z; Zhang P
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5015-7. PubMed ID: 18722119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a new class of selective nonsteroidal progesterone receptor agonists.
    Dong Y; Roberge JY; Wang Z; Wang X; Tamasi J; Dell V; Golla R; Corte JR; Liu Y; Fang T; Anthony MN; Schnur DM; Agler ML; Dickson JK; Lawrence RM; Prack MM; Seethala R; Feyen JH
    Steroids; 2004 Mar; 69(3):201-17. PubMed ID: 15072922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrinological properties of two novel nonsteroidal progesterone receptor modulators, CP8816 and CP8863.
    Kurata Y; Tabata Y; Shinei R; Iizuka Y; Masuda NT; Kurihara K; Okonogi T; Hoshiko S
    J Pharmacol Exp Ther; 2005 May; 313(2):916-20. PubMed ID: 15743919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New progesterone receptor antagonists: phosphorus-containing 11beta-aryl-substituted steroids.
    Jiang W; Allan G; Fiordeliso JJ; Linton O; Tannenbaum P; Xu J; Zhu P; Gunnet J; Demarest K; Lundeen S; Sui Z
    Bioorg Med Chem; 2006 Oct; 14(19):6726-32. PubMed ID: 16806946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-Aryl-1,4-dihydro-benzo[d][1,3]oxazin- 2-ones: a novel class of potent, selective, and orally active nonsteroidal progesterone receptor antagonists.
    Zhang P; Terefenko EA; Fensome A; Wrobel J; Winneker R; Lundeen S; Marschke KB; Zhang Z
    J Med Chem; 2002 Sep; 45(20):4379-82. PubMed ID: 12238914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-arylcoumarins as novel nonsteroidal type progesterone antagonists: an example with receptor-binding-dependent fluorescence.
    Sakai H; Hirano T; Mori S; Fujii S; Masuno H; Kinoshita M; Kagechika H; Tanatani A
    J Med Chem; 2011 Oct; 54(20):7055-65. PubMed ID: 21916484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal human progesterone receptor modulators from the marine alga Cymopolia barbata.
    Pathirana C; Stein RB; Berger TS; Fenical W; Ianiro T; Mais DE; Torres A; Goldman ME
    Mol Pharmacol; 1995 Mar; 47(3):630-5. PubMed ID: 7700260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and SAR of new pyrrole-oxindole progesterone receptor modulators leading to 5-(7-fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile (WAY-255348).
    Fensome A; Adams WR; Adams AL; Berrodin TJ; Cohen J; Huselton C; Illenberger A; Kern JC; Hudak VA; Marella MA; Melenski EG; McComas CC; Mugford CA; Slayden OD; Yudt M; Zhang Z; Zhang P; Zhu Y; Winneker RC; Wrobel JE
    J Med Chem; 2008 Mar; 51(6):1861-73. PubMed ID: 18318463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SAR studies of 6-(arylamino)-4,4-disubstituted-1-methyl-1,4-dihydro-benzo[d][1,3]oxazin-2-ones as progesterone receptor antagonists.
    Kern JC; Terefenko EA; Fensome A; Unwallla R; Wrobel J; Zhu Y; Cohen J; Winneker R; Zhang Z; Zhang P
    Bioorg Med Chem Lett; 2007 Jan; 17(1):189-92. PubMed ID: 17027272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological evaluation of aryl aminosulfonamide derivatives as potent 5-HT(6) receptor antagonists.
    Nirogi RV; Daulatabad AV; Parandhama G; Mohammad S; Sastri KR; Shinde AK; Dubey PK
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4440-3. PubMed ID: 20594839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological activity of 5-methylidene 1,2-dihydrochromeno[3,4-f]quinoline derivatives as progesterone receptor modulators.
    Zhi L; Tegley CM; Pio B; Edwards JP; Jones TK; Marschke KB; Mais DE; Risek B; Schrader WT
    Bioorg Med Chem Lett; 2003 Jun; 13(12):2071-4. PubMed ID: 12781197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, resolution, and biological evaluation of 5-aryl-1, 2-dihydro-5H-chromeno[3,4-f]quinolines: potent, orally active, nonsteroidal progesterone receptor agonists.
    Edwards JP; Zhi L; Pooley CL; Tegley CM; West SJ; Wang MW; Gottardis MM; Pathirana C; Schrader WT; Jones TK
    J Med Chem; 1998 Jul; 41(15):2779-85. PubMed ID: 9667968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of orally active, pyrrolidinone-based progesterone receptor partial agonists.
    Washburn DG; Hoang TH; Frazee JS; Johnson L; Hammond M; Manns S; Madauss KP; Williams SP; Duraiswami C; Tran TB; Stewart EL; Grygielko ET; Glace LE; Trizna W; Nagilla R; Bray JD; Thompson SK
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4664-8. PubMed ID: 19616429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Benzylidene 1,2-dihydrochromeno[3,4-f]quinolines, a novel class of nonsteroidal human progesterone receptor agonists.
    Tegley CM; Zhi L; Marschke KB; Gottardis MM; Yang Q; Jones TK
    J Med Chem; 1998 Oct; 41(22):4354-9. PubMed ID: 9784110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.